NCT05054725 2026-01-06Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesRevolution Medicines, Inc.Phase 2 Completed47 enrolled 17 charts
NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled
NCT04768296 2024-09-26Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)EMD SeronoPhase 2 Completed76 enrolled 42 charts
NCT01204099 2018-05-16Study of PX-866 and Docetaxel in Solid TumorsSeagen Inc.Phase 1/2 Completed223 enrolled
NCT01470209 2018-03-19A Phase I Study of BKM120 and Everolimus in Advanced Solid MalignanciesEmory UniversityPhase 1 Completed43 enrolled